Publications

Export 1755 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2019
Hasford J, Nelson G, S Worton K, Macnaughton E, MacLeod T, Piat M, Tsemberis S, Stergiopoulos V, Distasio J, Aubry T et al..  2019.  Knowledge translation and implementation of housing first in Canada: A qualitative assessment of capacity building needs for an evidence-based program.. Eval Program Plann. 75:1-9.
Hasford J, Nelson G, S Worton K, Macnaughton E, MacLeod T, Piat M, Tsemberis S, Stergiopoulos V, Distasio J, Aubry T et al..  2019.  Knowledge translation and implementation of housing first in Canada: A qualitative assessment of capacity building needs for an evidence-based program.. Eval Program Plann. 75:1-9.
Bedford SA, Park MTae M, Devenyi GA, Tullo S, Germann J, Patel R, Anagnostou E, Baron-Cohen S, Bullmore ET, Chura LR et al..  2019.  Large-scale analyses of the relationship between sex, age and intelligence quotient heterogeneity and cortical morphometry in autism spectrum disorder.. Mol Psychiatry.
Bedford SA, Park MTae M, Devenyi GA, Tullo S, Germann J, Patel R, Anagnostou E, Baron-Cohen S, Bullmore ET, Chura LR et al..  2019.  Large-scale analyses of the relationship between sex, age and intelligence quotient heterogeneity and cortical morphometry in autism spectrum disorder.. Mol Psychiatry.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
McGihon RE, Burns RJ, Deschênes SS, Schmitz N.  2019.  Longitudinal associations between number of cigarettes per day and depressive symptoms in adult smokers with type 2 diabetes: A path analysis approach.. J Psychosom Res. 125:109737.
Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER et al..  2019.  Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.. Alzheimers Dement. 15(6):742-753.
Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER et al..  2019.  Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.. Alzheimers Dement. 15(6):742-753.
Iyer SN, Mustafa S, Abadi S, Joober R, Malla A.  2019.  Look Before You Leap: Representativeness of Those Completing Self-Reports in Early Psychosis Research.. Can J Psychiatry. :706743719879356.
Iyer SN, Mustafa S, Abadi S, Joober R, Malla A.  2019.  Look Before You Leap: Representativeness of Those Completing Self-Reports in Early Psychosis Research.. Can J Psychiatry. :706743719879356.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Daneault J-G, Maraj A, Lepage M, Malla A, Schmitz N, Iyer SN, Joober R, Shah JL.  2019.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.. Acta Psychiatr Scand. 139(4):336-347.
Daneault J-G, Maraj A, Lepage M, Malla A, Schmitz N, Iyer SN, Joober R, Shah JL.  2019.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.. Acta Psychiatr Scand. 139(4):336-347.
Thaler L, Brassard S, Booij L, Kahan E, McGregor K, Labbe A, Israel M, Steiger H.  2019.  Methylation of the OXTR gene in women with anorexia nervosa: Relationship to social behavior.. Eur Eat Disord Rev.
Salamanca L, Mechawar N, Murai KK, Balling R, Bouvier DS, Skupin A.  2019.  MIC-MAC: An automated pipeline for high-throughput characterization and classification of three-dimensional microglia morphologies in mouse and human postmortem brain samples.. Glia. 67(8):1496-1509.
Salamanca L, Mechawar N, Murai KK, Balling R, Bouvier DS, Skupin A.  2019.  MIC-MAC: An automated pipeline for high-throughput characterization and classification of three-dimensional microglia morphologies in mouse and human postmortem brain samples.. Glia. 67(8):1496-1509.
S Torres-Platas G, Escobar S, Belliveau C, Wu J, Sasi N, Fotso J, Potes A, Thomas Z, Goodman A, Looper K et al..  2019.  Mindfulness-Based Cognitive Therapy Intervention for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial.. Psychother Psychosom. 88(4):254-256.
Iyer SN, Shah JL, Boksa P, Lal S, Joober R, Andersson N, Fuhrer R, Abdel-Baki A, Beaton AM, Reaume-Zimmer P et al..  2019.  A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project. BMC psychiatry. 19(1):273-273.
Iyer SN, Shah JL, Boksa P, Lal S, Joober R, Andersson N, Fuhrer R, Abdel-Baki A, Beaton AM, Reaume-Zimmer P et al..  2019.  A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project. BMC psychiatry. 19(1):273-273.
Iyer SN, Shah JL, Boksa P, Lal S, Joober R, Andersson N, Fuhrer R, Abdel-Baki A, Beaton AM, Reaume-Zimmer P et al..  2019.  A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project.. BMC Psychiatry. 19(1):273.

Pages